FRIEDBERG EZRA M sold 25.0% of their position (10K shares) of PELTHOS THERAPEUTICS INC. on the open market
Open‑market sale worth $280.3K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 11/26/2025ACC: 0001753926-25-001831
Director10% Owner
Since Feb 2024
-10K
Net shares
Net seller
$280.3K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
10K disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−6K
Price / share
$28.00
Trade value
$167.97K
% of position
15.0%
11/25/2025
40K→34K
Common Stock
Indirect
Shares
−2K
Price / share
$28.14
Trade value
$56.27K
% of position
5.9%
11/25/2025
34K→32K
Common Stock
Indirect
Shares
−1.00
Price / share
$28.50
Trade value
$28.50
% of position
0.0%
11/25/2025
32K→32K
Common Stock
Indirect
Shares
−2K
Price / share
$28.00
Trade value
$56.01K
% of position
6.3%
11/25/2025
32K→30K
Total
Net shares
−10K
Net value
-$280.28K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/25/2025 | S · Sale | −6K | $28.00 | $167.97K | 15.0% | 40K | 34K |
| Common Stock Indirect | 11/25/2025 | S · Sale | −2K | $28.14 | $56.27K | 5.9% | 34K | 32K |
| Common Stock Indirect | 11/25/2025 | S · Sale | −1.00 | $28.50 | $28.50 | 0.0% | 32K | 32K |
| Common Stock Indirect | 11/25/2025 | S · Sale | −2K | $28.00 | $56.01K | 6.3% | 32K | 30K |
| Total | −10K | -$280.28K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned40K
Common Stock
DirectShares owned54.57K
Total
54.57K direct·40K indirect94.57K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 40K | Indirect |
| Common Stock | 54.57K | Direct |
| Total | 94.57K | 54.57K direct·40K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported